Sedana Medical AB (OSTO:SEDANA) Short-Term Debt: kr4.5 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:SEDANA Sedana Medical AB OSTO:SEDANA
73 GF Score
Price kr10.00
GF Value kr17.02
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Sedana Medical AB Short-Term Debt?

Sedana Medical AB OSTO:SEDANA -6.72% 73 Short-Term Debt is kr4.5 Mil as of Jun. 2026. GuruFocus rates OSTO:SEDANA with a GF Score™ of 73/100 and a GF Value™ of kr17.02 (Significantly Undervalued). The stock has 2 warning signs investors should review.

Sedana Medical AB's Short-Term Debt for the quarter that ended in Jun. 2026 was kr4.5 Mil.

Sedana Medical AB's quarterly Short-Term Debt increased from Dec. 2025 (kr2.8 Mil) to Mar. 2026 (kr4.1 Mil) and increased from Mar. 2026 (kr4.1 Mil) to Jun. 2026 (kr4.5 Mil).

Sedana Medical AB's annual Short-Term Debt increased from Dec. 2023 (kr3.3 Mil) to Dec. 2024 (kr3.3 Mil) but then declined from Dec. 2024 (kr3.3 Mil) to Dec. 2025 (kr2.8 Mil).

Sedana Medical AB Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Sedana Medical AB Short-Term Debt Related Terms

Sedana Medical AB Short-Term Debt Historical Data

* Premium members only.

The historical data trend for Sedana Medical AB's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sedana Medical AB Short-Term Debt Chart

Sedana Medical AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.23 5.17 3.29 3.33 2.81

Sedana Medical AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.65 2.25 2.81 4.10 4.46
OSTO:SEDANA
73GF Score
Sedana Medical AB OSTO:SEDANA
Short-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of kr4.5 Mil mean?
Sedana Medical AB (OSTO:SEDANA) has a Short-Term Debt of kr4.5 Mil as of Jun. 2026.
Is Sedana Medical AB's Short-Term Debt too high?
Sedana Medical AB's current Short-Term Debt is kr4.5 Mil. Overall, Sedana Medical AB has a GF Score™ of 73/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sedana Medical AB's Short-Term Debt compare to ABT and SYK?
Sedana Medical AB's Short-Term Debt of kr4.5 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for a Medical Devices & Instruments company?
A good Short-Term Debt depends on the Medical Devices & Instruments industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. Sedana Medical AB's current Short-Term Debt is kr4.5 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sedana Medical AB stock overvalued right now?
Based on GuruFocus' analysis, Sedana Medical AB (OSTO:SEDANA) is currently considered Significantly Undervalued. The stock's GF Value™ is kr17.02, compared to a current price of kr10.00 — trading 41.2% below its estimated fair value. The current Short-Term Debt is kr4.5 Mil. Sedana Medical AB's overall GF Score™ is 73/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For Sedana Medical AB (OSTO:SEDANA), the current Short-Term Debt is kr4.5 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sedana Medical AB (OSTO:SEDANA) Overvalued in 2026?

Based on GuruFocus' analysis, Sedana Medical AB stock appears to be undervalued. The current stock price of kr10.00 is trading 41.2% below its estimated GF Value™ of kr17.02. GuruFocus considers Sedana Medical AB to be Significantly Undervalued.

Key valuation signals for OSTO:SEDANA:

  • Short-Term Debt: kr4.5 Mil
  • GF Value™: kr17.02 vs. price of kr10.00 (41.2% below fair value)
  • GF Score™: 73/100 with 2 warning signs

No single metric tells the full story. See the OSTO:SEDANA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sedana Medical AB Business Description

Other Exchanges 7D2A:Germany
Address Svardvagen 3A, Danderyd, SWE, SE-182 33
Sedana Medical AB is a Sweden-based medical technology company. It is ais a pioneer medtech and pharmaceutical company focused on inhaled sedation to improve the patient's life during and beyond sedation. Through the combined strengths of the medical device Sedaconda ACD and the pharmaceutical Sedaconda (isoflurane), Sedana Medical provides inhaled sedation for mechanically ventilated patients in intensive care. Sedana Medical has direct sales in Benelux, France, Germany, Great Britain, and Spain. In other parts of Europe, as well as in Asia, Australia, Canada, and South and Central America, the company works with external distributors.
73GF Score

Get the complete analysis for OSTO:SEDANA

Short-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr10.00
Price
kr17.02
GF Value